MedPath
PPB Approval

EYLEA SOLUTION FOR INTRAVITREAL INJECTION 114.3MG/ML

HK-68359

Prescription only Medicines

September 6, 2024

Company Information

Company Details

14/F, OXFORD HOUSE, TAIKOO PLACE, 979 KING’S ROAD, QUARRY BAY, HONG KONG

Active Ingredients

aflibercept

Drug Monographs

Aflibercept

阿柏西普

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EYLEA SOLUTION FOR INTRAVITREAL INJECTION 114.3MG/ML - PPB 批准文号 | MedPath